Open main menu
Search Ctrl + K
Free Trial
Loading...
Y-mabs Therapeutics, Inc.
Watch
Pharmaceutical Preparations
NASDAQ.YMAB
230 Park Avenue, Suite 3350, New York, NY, 10169
Categorized
Chronological
Ownership by Owner
Insider Transactions
Institutional Owners
Filings by Form Type
Transcripts
Your Highlights
Search Within Documents
Key Exhibits
Articles & Bylaws
Indentures
Material contracts
Plans of Reorganization
Underwriting Agreements
External Links
Google Finance
SEC EDGAR
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
News
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
04 Mar 25
8-K
Entry Into A Material Definitive Agreement, Financial Statements And Exhibits
04 Mar 25
8-K
Regulation Fd Disclosure
13 Jan 25
8-K
Results Of Operations And Financial Condition, Cost Associated With Exit Or Disposal Activities, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Regulation Fd Disclosure, Financial Statements And Exhibits
10 Jan 25
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
08 Nov 24
8-K
Entry Into A Material Definitive Agreement, Regulation Fd Disclosure, Financial Statements And Exhibits
04 Nov 24
8-K
Other Events
20 Sep 24
Prospectuses and Registrations
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
04 Mar 25
424B5
Prospectus Filed Pursuant To Rule 424(b)(5).
04 Mar 25
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
29 Feb 24
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
30 Mar 23
424B5
Prospectus Filed Pursuant To Rule 424(b)(5).
18 Feb 21
424B5
Prospectus Filed Pursuant To Rule 424(b)(5).
17 Feb 21
424B5
Prospectus Filed Pursuant To Rule 424(b)(5).
31 Oct 19
Other
ARS
Scanned Paper Annual Report Submission.
29 Apr 24
EFFECT
Notice Of Effectiveness For A Previously Filed Sec Document.
05 May 23
CORRESP
Correspondence With The Sec.
02 May 23
ARS
Scanned Paper Annual Report Submission.
28 Apr 23
UPLOAD
Letter From The Sec.
03 Apr 23
S-3
Registration Statement Under The Securities Act.
30 Mar 23
SEC STAFF LETTER
Correspondence Between The Sec's Staff And Filers.
28 Feb 20
Ownership
4
Gad Thomas
11 Mar 25
4
Rossi Michael J
11 Mar 25
144
Rossi Michael J
07 Mar 25
144
Smith Susan Laura
07 Mar 25
144
Rajah Vignesh
07 Mar 25
144
Gad Thomas
07 Mar 25
4
Wilms Joris
22 Jan 25
Financials
10-K
Fiscal Year 2024
04 Mar 25
10-Q
Quarterly Filing
08 Nov 24
10-Q
Quarterly Filing
12 Aug 24
10-Q
Quarterly Filing
07 May 24
10-K
Fiscal Year 2024
29 Feb 24
10-Q
Quarterly Filing
13 Nov 23
10-Q
Quarterly Filing
10 Aug 23
Proxies
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
29 Apr 24
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
29 Apr 24
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
28 Apr 23
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
28 Apr 23
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
29 Apr 22
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
29 Apr 22
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
28 Apr 21